politics #Healthcare #Policy #Cagrilintide #CagriSema #EliLilly #Fda #GLP1Drugs #NextGeneration #NovoNordisk #Semaglutide #Tirzepatide #Wegovy #WeightLossDrugs #Zepbound Novo Nordisk's next-gen weight loss drug outperforms Zepbound in new trial The Hill Sep 28
BURST